Clinical trial
A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In…
NCT00116883 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00116883 |
|---|---|
| Title | A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics |
| Official title | A Randomized, Double-blind, Parallel Group, Placebo Controlled, 6-week Study of the Effect of GW685698X Aqueous Nasal Spray 100mcg QD on the Hypothalamic Pituitary Adrenocortical (HPA) Axis in Children 2 to 11 Years of Age With Perennial Allergic Rhinitis (PAR). |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | GW685698X aqueous nasal spray |
| Enrollment | 90 |
| Start date | Feb 1, 2005 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Jul 1, 2005 |
| Last update posted | Sep 15, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: